Nuvation Bio (NWN) Upgraded by Zacks Investment Research to Buy

Nuvation Bio stock has undergone multiple analysts rating changes in the recent past.  Nuvation Bio Upgraded by Zacks Investment Research on 10/13/2021. In a note to investors, the firm issued a new rating of Buy. The analysts previously had rating of Hold.

Shares of Nuvation Bio traded up $0.10 on Tuesday, reaching $9.50. 0 shares of the stock traded hands, compared to its average volume of 704501. Shares of Nuvation Bio were trading at $9.50 on Tuesday. The firm’s 50 day moving average is $49.86 and its 200 day moving average is $50.82.Nuvation Bio has a 12 month low of $9.37 and a 12 month high of $15.23. While on yearly highs and lows, Nuvation Bio’s today has traded high as $9.53 and has touched $9.37 on the downward trend. See More Analyst Rating at: RATING

Nuvation Bio Earnings and What to expect: 

Northwest Natural last posted its quarterly earnings results on August 5th, 2021. The utilities provider reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.11. The business earned $148.90 million during the quarter, compared to analyst estimates of $142.64 million. Its revenue was up 10.4% on a year-over-year basis. Northwest Natural has generated $2.30 earnings per share over the last year ($3.03 diluted earnings per share) and currently has a price-to-earnings ratio of 15.4. Earnings for Northwest Natural are expected to grow by 3.49% in the coming year, from $2.58 to $2.67 per share. Northwest Natural has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, November 4th, 2021 based off prior year’s report dates.

Earnings for Northwest Natural are expected to grow by 3.49% in the coming year, from $2.58 to $2.67 per share. The P/E ratio of Northwest Natural is 15.42, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.78. The P/E ratio of Northwest Natural is 15.42, which means that it is trading at a more expensive P/E ratio than the Utilities sector average P/E ratio of about 14.19. Northwest Natural has a PEG Ratio of 3.87. PEG Ratios above 1 indicate that a company could be overvalued. Northwest Natural has a P/B Ratio of 1.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Nuvation Bio (NWN) Moving Average Technical Analysis

5 day Moving Average is $46.90 And 5 day price change is -$0.37 (-0.79%)  with average volume for 5 day average is 94,040. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $46.94 and 20 day price change is -$1.41 (-2.93%) and average 20 day moving volume is 121,960. 50 day moving average is $49.86  and 50 day price change is -$6.30 ( -11.88%)  and with average volume for 50 days is : 109,952. 200 day moving average is $50.82  and 200 day price change is $1.02 (2.23%)  and with average volume for 200 days is : 217,880.

Other owners latest trading in Nuvation Bio :

  • On 10/12/2021 shares held by Louisiana State Employees Retirement System were 14,800 which equates to market value of $0.68M and appx 0.00% owners of Nuvation Bio
  • On 10/12/2021 shares held by Hennessy Advisors Inc. were 72,703 which equates to market value of $3.34M and appx 0.20% owners of Nuvation Bio
  • On 10/8/2021 shares held by Creative Financial Designs Inc. ADV were 6,672 which equates to market value of $0.31M and appx 0.10% owners of Nuvation Bio
  • In total Institutional ownership equates to Institutional Ownership Percentage: 69.86% for Nuvation Bio

See More Analyst Rating at: RATING